TY - JOUR
T1 - Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids
AU - Orellana, Minerva
AU - Riggan, Kirsten A.
AU - DSouza, Karen
AU - Stewart, Elizabeth A.
AU - Venable, Sateria
AU - Balls-Berry, Joyce E.
AU - Allyse, Megan A.
N1 - Funding Information:
The authors would like to thank The Fibroid Foundation and the women who volunteered to share their experiences with us. We also wish to thank Anna Gilbert for her assistance in the data analysis. Part of this work was presented at the 2018 American Society for Bioethics & Humanities conference.
Funding Information:
This project was funded by Mayo Clinic’s Office of Health Disparities Research. The Office of Health Disparities Research had no involvement in the conduct of the research and the preparation and submission of the manuscript. This publication was also supported by CTSA Grant Number TL1 TR002380 from the National Center for Advancing Translational Science (NCATS). Ms. Riggan (KR) and Dr. Allyse (MA) are funded by the Mayo Clinic Department of Obstetrics and Gynecology, and Dr. Allyse is additionally funded by NHGRI grant K01 HG009642. Dr. Balls-Berry (JBB) is funded by PPRN-1501-26817, TR 02494, and HS023418.
Funding Information:
The authors MO, KR, KD, and MA report no conflicts of interest. EAS, JBB, and SV report additional funding from the Agency for Healthcare Research and Quality grant P50HS023418. JBB reports consultation with Boston Scientific and Parabon NanoLabs, Inc. EAS reports consulting for AbbVie, Bayer, ObsEva, and Myovant related to uterine fibroids and payment for development of educational content from UpToDate, Med Learning Group, PER, and Peer View. SV reports consulting for AbbVie, Myovant, Bayer.
Publisher Copyright:
© 2021, W. Montague Cobb-NMA Health Institute.
PY - 2022/8
Y1 - 2022/8
N2 - Background: Uterine fibroids are non-cancerous neoplasms of the uterus. Women of color, including non-Hispanic Black/African American women and Hispanic/Latinas, have a higher uterine fibroid prevalence, incidence, and disease burden compared to non-Hispanic White women. Therefore, understanding ethnoracial factors in the diagnosis and treatment of uterine fibroids in women of color is critical. This study provides insight on the ethnoracial factors and cultural barriers experienced by women of color in the management and treatment of uterine fibroids. Methods: Women were recruited via The Fibroid Foundation, a nonprofit that provides uterine fibroid support and education. Women who were interested completed an online screening survey. Eligible participants were interviewed via phone. Transcribed audio recordings were qualitatively analyzed using the principles of grounded theory. Results: Forty-seven women of reproductive age who were diagnosed with uterine fibroids and received U.S.-based care participated in a semi-structured interview exploring experiences with uterine fibroid diagnosis and management. Twenty-eight women self-identified as Black, Latina, or other ethnicity. Women of color reported fibroid symptoms that significantly disrupted their work and home life. Women of color also reported perceptions that their race/ethnicity impacted their uterine fibroid treatment, including negative interpersonal provider-patient interactions. These perceptions engendered feelings of skepticism towards the medical system based on historical injustices and/or their own negative experiences and led some to go without longitudinal care. Conclusion: Cultural and familial factors have significant impact on uterine fibroid diagnosis and management. Greater attention to culturally sensitive care and potential bias reduction in the treatment of uterine fibroids should be a priority.
AB - Background: Uterine fibroids are non-cancerous neoplasms of the uterus. Women of color, including non-Hispanic Black/African American women and Hispanic/Latinas, have a higher uterine fibroid prevalence, incidence, and disease burden compared to non-Hispanic White women. Therefore, understanding ethnoracial factors in the diagnosis and treatment of uterine fibroids in women of color is critical. This study provides insight on the ethnoracial factors and cultural barriers experienced by women of color in the management and treatment of uterine fibroids. Methods: Women were recruited via The Fibroid Foundation, a nonprofit that provides uterine fibroid support and education. Women who were interested completed an online screening survey. Eligible participants were interviewed via phone. Transcribed audio recordings were qualitatively analyzed using the principles of grounded theory. Results: Forty-seven women of reproductive age who were diagnosed with uterine fibroids and received U.S.-based care participated in a semi-structured interview exploring experiences with uterine fibroid diagnosis and management. Twenty-eight women self-identified as Black, Latina, or other ethnicity. Women of color reported fibroid symptoms that significantly disrupted their work and home life. Women of color also reported perceptions that their race/ethnicity impacted their uterine fibroid treatment, including negative interpersonal provider-patient interactions. These perceptions engendered feelings of skepticism towards the medical system based on historical injustices and/or their own negative experiences and led some to go without longitudinal care. Conclusion: Cultural and familial factors have significant impact on uterine fibroid diagnosis and management. Greater attention to culturally sensitive care and potential bias reduction in the treatment of uterine fibroids should be a priority.
KW - Ethnoracial factors
KW - Health disparities
KW - Racism
KW - Uterine fibroids
KW - Uterine leiomyoma
UR - http://www.scopus.com/inward/record.url?scp=85106240836&partnerID=8YFLogxK
U2 - 10.1007/s40615-021-01059-8
DO - 10.1007/s40615-021-01059-8
M3 - Article
C2 - 34013445
AN - SCOPUS:85106240836
VL - 9
SP - 1184
EP - 1191
JO - Journal of Racial and Ethnic Health Disparities
JF - Journal of Racial and Ethnic Health Disparities
SN - 2197-3792
IS - 4
ER -